相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Systematic analysis of berberine-induced signaling pathway between miRNA clusters and mRNAs and identification of mir-99a∼125b cluster function by seed-targeting inhibitors in multiple myeloma cells
Maoxiao Feng et al.
RNA BIOLOGY (2015)
Composition of seed sequence is a major determinant of microRNA targeting patterns
Xiaowei Wang
BIOINFORMATICS (2014)
Integrative analysis of differential miRNA and functional study of miR-21 by seed-targeting inhibition in multiple myeloma cells in response to berberine
Xiaochuang Luo et al.
BMC SYSTEMS BIOLOGY (2014)
miR-92a family and their target genes in tumorigenesis and metastasis
Molin Li et al.
EXPERIMENTAL CELL RESEARCH (2014)
Inhibition of microRNA miR-92a induces apoptosis and inhibits cell proliferation in human acute promyelocytic leukemia through modulation of p63 expression
Mohammadreza Sharifi et al.
MOLECULAR BIOLOGY REPORTS (2014)
MicroRNA-21 and multiple myeloma: small molecule and big function
Jing Ma et al.
MEDICAL ONCOLOGY (2014)
MiR-19a/b modulate the metastasis of gastric cancer cells by targeting the tumour suppressor MXD1
Q. Wu et al.
CELL DEATH & DISEASE (2014)
Set9, NF-kappa B, and microRNA-21 mediate berberine-induced apoptosis of human multiple myeloma cells
Hai-yan Hu et al.
ACTA PHARMACOLOGICA SINICA (2013)
miR-19a Promotes Cell Growth and Tumorigenesis through Targeting SOCS1 in Gastric Cancer
Shuang Qin et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
Serum miR-19a Predicts Resistance to FOLFOX Chemotherapy in Advanced Colorectal Cancer Cases
Qi Chen et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
Overexpression of miR-92a correlates with tumor metastasis and poor prognosis in patients with colorectal cancer
Tong Zhou et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2013)
JAK/STAT/SOCS-signaling pathway and colon and rectal cancer
Martha L. Slattery et al.
MOLECULAR CARCINOGENESIS (2013)
HDAC Inhibitors Repress BARD1 Isoform Expression in Acute Myeloid Leukemia Cells via Activation of miR-19a and/or b
Ilaria Lepore et al.
PLOS ONE (2013)
Pharmacological Inhibition of a MicroRNA Family in Nonhuman Primates by a Seed-Targeting 8-Mer AntimiR
Veerle Rottiers et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Molecular pathogenesis of multiple myeloma and its premalignant precursor
W. Michael Kuehl et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
miR-17-92 cluster microRNAs confers tumorigenicity in multiple myeloma
Lijuan Chen et al.
CANCER LETTERS (2011)
miR-92 is a key oncogenic component of the miR-17-92 cluster in colon cancer
Akihiko Tsuchida et al.
CANCER SCIENCE (2011)
Environmental chemicals and microRNAs
Lifang Hou et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2011)
Silencing of microRNA families by seed-targeting tiny LNAs
Susanna Obad et al.
NATURE GENETICS (2011)
MicroRNA Expression Signatures of Bladder Cancer Revealed by Deep Sequencing
Yonghua Han et al.
PLOS ONE (2011)
Elevated Expression of APE1/Ref-1 and its Regulation on IL-6 and IL-8 in Bone Marrow Stromal Cells of Multiple Myeloma
Jia-Yin Xie et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2010)
MicroRNA 92a-2 A Biomarker Predictive for Chemoresistance and Prognostic for Survival in Patients with Small Cell Lung Cancer
Aarati R. Ranade et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
The Hemopoietic Stem Cell Niche Versus the Microenvironment of the Multiple Myeloma-Tumor Initiating Cell
Dov Zipori
CANCER MICROENVIRONMENT (2010)
MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes
Mika Inomata et al.
BLOOD (2009)
Identification of microRNA expression patterns and definition of a microRNA/mRNA regulatory network in distinct molecular groups of multiple myeloma
Marta Lionetti et al.
BLOOD (2009)
Genetic dissection of the miR-17∼92 cluster of microRNAs in Myc-induced B-cell lymphomas
Ping Mu et al.
GENES & DEVELOPMENT (2009)
miR-19 is a key oncogenic component of mir-17-92
Virginie Olive et al.
GENES & DEVELOPMENT (2009)
Berberine and Coptidis Rhizoma as novel antineoplastic agents: A review of traditional use and biomedical investigations
Jun Tang et al.
JOURNAL OF ETHNOPHARMACOLOGY (2009)
Inhibition of microRNA with antisense oligonucleotides
Christine C. Esau
METHODS (2008)
Berberine inhibits TPA-induced MMP-9 and IL-6 expression in normal human keratinocytes
Sangmin Kim et al.
PHYTOMEDICINE (2008)
MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis
Flavia Pichiorri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Traditional Chinese Medicine in Treatment of Metabolic Syndrome
Jun Yin et al.
Endocrine Metabolic & Immune Disorders-Drug Targets (2008)
Berberine inhibits the expression of TNFα, MCP-1, and IL-6 in AcLDL-stimulated macrophages through PPARγ pathway
F. L. Chen et al.
ENDOCRINE (2008)
Emerging role of MicroRNAs in cardiovascular biology
Michael V. G. Latronico et al.
CIRCULATION RESEARCH (2007)
OncomiRs: the discovery and progress of microRNAs in cancers
William C. S. Cho
MOLECULAR CANCER (2007)
Global analysis of microRNA target gene expression reveals that miRNA targets are lower expressed in mature mouse and Drosophila tissues than in the embryos
Zhenbao Yu et al.
NUCLEIC ACIDS RESEARCH (2007)
Oncomirs - microRNAs with a role in cancer
A Esquela-Kerscher et al.
NATURE REVIEWS CANCER (2006)
Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis
AM Cheng et al.
NUCLEIC ACIDS RESEARCH (2005)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
The anti-inflammatory potential of berberine in vitro and in vivo
CL Kuo et al.
CANCER LETTERS (2004)
Micrornas: Small RNAs with a big role in gene regulation
L He et al.
NATURE REVIEWS GENETICS (2004)
Anticachectic effects of the natural herb Coptidis rhizoma and berberine on mice bearing colon 26/clone 20 adenocarcinoma
N Iizuka et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Anticachectic effects of Coptidis rhizoma, an anti-inflammatory herb, on esophageal cancer cells that produce interleukin 6
N Iizuka et al.
CANCER LETTERS (2000)